This article was originally published in The Tan Sheet
House, Senate pass continuing resolution (H.J. Res. 1) to extend FY 2002 funding levels for government agencies until Jan. 31. Chambers still have to pass 10 of 13 appropriations bills, which could be included in an omnibus spending measure discussed as early as the week of Jan. 13 in the Senate. House Appropriations Committee Chairman Bill Young (R-Fla.) reiterates concerns long-term CR funding at 2002 levels "would have disastrous impacts on the war on terror, homeland security and other important government responsibilities"...
You may also be interested in...
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.
“This is truly uncharted territory because we’ve never had this situation,” says CHPA regulatory VP David Spangle. Asking Congress instead to instruct FDA to first determine a safe daily limit would be a threatening precedent for the supplement market, says CRN CEO Steve Mister. “That really turns DSHEA on its head.”